Join us for an exciting new event on the latest research on the full patient pathway across the key urological cancers, developing an understanding of the role played by different members of the MDT in providing evidence-based care and the impact cancer has on patients including survivorship and palliative support.
Building on last year's Urology Section Cancer Day, this event will feature internationally renowned speakers from across the urology MDT including urologists, radiologists, oncologists, pathologists and specialist nurses. In doing so, we will provide a unique holistic insight into the management of patients with urological cancers relevant to those involved in caring for these patients and those studying for the FRCS(Urol) exam.
The day will include updates on the management of penile cancer, metastatic prostate cancer, non-muscle invasive bladder cancer (NMIBC) and localised kidney cancer. We will also gain an insight on how survivorship from various urological cancers has changed over time including for young men treated for testis cancer and the role of patient charities.
The Urology Section's Malcolm Coptcoat Short Papers Prize sponsored by The Urology Foundation will also be presented and awarded at the meeting. Click here to make your submission.
Participants will learn about:
- Management of penile cancer
- Role of patient charities
- Management of NMIBC
- Management of metastatic prostate cancer
- The surgical treatment of localized kidney cancer
- The impact of treatment of testis cancer
--------------
Interested in applying for the Malcolm Coptcoat Short Papers Prize sponsored by The Urology Foundation?
Deadline: Saturday 12 October 2024
Open to: All Urological Trainees and SAS Doctors working in Urology
Prizes:
1st: £600 towards the Urological Education
2nd: £300 towards the Urological Education
3rd: £150 towards the Urological Education
Apply here
Follow us on:
Facebook
Instagram
LinkedIn
Twitter
YouTube
We would like to thank our sponsors Accord, Astellas, Bayer, iMEDicare, Ipsen, Medac Pharma and our exhibitor Photocure for their support and funding of this event. We would also like to thank Prostate Cancer UK who have provided funding towards this event via an education bursary. Please note that the main scientific programme and content has not been influenced in any way by the organisations listed above.